A Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of UCB0022 in Study Participants With Advanced Parkinson's Disease
Public ClinicalTrials.gov record NCT06055985. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter Phase 2, Double-blind, Placebo-controlled, Randomized, Parallel-group Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of UCB0022 in Study Participants With Advanced Parkinson's Disease
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary purpose of this study is to demonstrate the superiority of UCB0022 as an adjunctive treatment to stable dose of standard-of-care (SoC) (including at least levodopa therapy) over placebo with regard to motor fluctuations time spent in the OFF state (OFF time) in study participants with advanced Parkinson's Disease (PD).
Study identification
- NCT ID
- NCT06055985
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 207 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 35 Years to 85 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 17, 2023 (Actual)
- Primary completion
- Mar 31, 2025 (Actual)
- Completion
- Apr 11, 2025 (Actual)
- Last update posted
- Apr 6, 2026
2023 – 2025
United States locations
- U.S. sites
- 61
- U.S. states
- 25
- U.S. cities
- 56
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pd0060 50506 | Phoenix | Arizona | 85004 | — |
| Pd0060 50590 | Scottsdale | Arizona | 85258 | — |
| Pd0060 50608 | Little Rock | Arkansas | 72205 | — |
| Pd0060 50519 | Fountain Valley | California | 92708 | — |
| Pd0060 50428 | Fresno | California | 93710 | — |
| Pd0060 50601 | Loma Linda | California | 92354 | — |
| Pd0060 50589 | Los Alamitos | California | 90720 | — |
| Pd0060 50587 | Los Angeles | California | 90033 | — |
| Pd0060 50452 | Pasadena | California | 91106 | — |
| Pd0060 50598 | Englewood | Colorado | 80113 | — |
| Pd0060 50628 | New Haven | Connecticut | 06519 | — |
| Pd0060 50610 | Newark | Delaware | 19713 | — |
| Pd0060 50600 | Altamonte Springs | Florida | 32714 | — |
| Pd0060 50616 | Aventura | Florida | 33180 | — |
| Pd0060 50596 | Boca Raton | Florida | 33486 | — |
| Pd0060 50524 | Bradenton | Florida | 34205 | — |
| Pd0060 50647 | DeLand | Florida | 32720 | — |
| Pd0060 50577 | Doral | Florida | 33172 | — |
| Pd0060 50584 | Hollywood | Florida | 33021 | — |
| Pd0060 50582 | Miami | Florida | 33122 | — |
| Pd0060 50579 | Miami | Florida | 33125 | — |
| Pd0060 50449 | Miami | Florida | 33133 | — |
| Pd0060 50580 | Miami | Florida | 33176 | — |
| Pd0060 50597 | Naples | Florida | 34105 | — |
| Pd0060 50591 | Ocala | Florida | 34470 | — |
| Pd0060 50605 | Port Orange | Florida | 32127 | — |
| Pd0060 50620 | St. Petersburg | Florida | 33710 | — |
| Pd0060 50603 | Tampa | Florida | 33609 | — |
| Pd0060 50585 | Winter Park | Florida | 32789 | — |
| Pd0060 50075 | Augusta | Georgia | 30912 | — |
| Pd0060 50595 | Indianapolis | Indiana | 46256 | — |
| Pd0060 50319 | Iowa City | Iowa | 52242 | — |
| Pd0060 50074 | Kansas City | Kansas | 66160 | — |
| Pd0060 50561 | Lexington | Kentucky | 40536-0284 | — |
| Pd0060 50615 | Boston | Massachusetts | 02118 | — |
| Pd0060 50085 | Boston | Massachusetts | 02215 | — |
| Pd0060 50627 | North Dartmouth | Massachusetts | 02747 | — |
| Pd0060 50110 | Ann Arbor | Michigan | 48109-0944 | — |
| Pd0060 50545 | East Lansing | Michigan | 48824 | — |
| Pd0060 50386 | Farmington Hills | Michigan | 48334 | — |
| Pd0060 50613 | Grand Rapids | Michigan | 49503 | — |
| Pd0060 50614 | New York | New York | 10021 | — |
| Pd0060 50521 | New York | New York | 10029 | — |
| Pd0060 50612 | Raleigh | North Carolina | 27607 | — |
| Pd0060 50087 | Centerville | Ohio | 45459 | — |
| Pd0060 50622 | Cleveland | Ohio | 44195 | — |
| Pd0060 50076 | Columbus | Ohio | 43221 | — |
| Pd0060 50604 | Dayton | Ohio | 45449 | — |
| Pd0060 50527 | Toledo | Ohio | 43614 | — |
| Pd0060 50398 | Tulsa | Oklahoma | 74136 | — |
| Pd0060 50607 | Portland | Oregon | 97210 | — |
| Pd0060 50619 | Rock Hill | South Carolina | 29732 | — |
| Pd0060 50496 | Round Rock | Texas | 78681 | — |
| Pd0060 50568 | San Antonio | Texas | 78229 | — |
| Pd0060 50537 | Salt Lake City | Utah | 84108 | — |
| Pd0060 50143 | Henrico | Virginia | 23233 | — |
| Pd0060 50534 | Virginia Beach | Virginia | 23456 | — |
| Pd0060 50440 | Bellevue | Washington | 98004 | — |
| Pd0060 50292 | Kirkland | Washington | 98034 | — |
| Pd0060 50419 | Spokane | Washington | 99202 | — |
| Pd0060 50402 | Crab Orchard | West Virginia | 25827 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06055985, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 6, 2026 · Synced Oct 29, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT06055985 live on ClinicalTrials.gov.